# MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction

Study · id `cardio:ct-nct01869738` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01869738](<https://clinicaltrials.gov/study/NCT01869738>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01869738

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 310 participants.

## Technical summary

Registry record NCT01869738. Randomized; single masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 310 participants (enrolled count; ClinicalTrials.gov record NCT01869738, source copy `cardio:ctgov-nct01869738-2015-09-02`, retrieved 2026-10-26)
- Start date: 2013-06 (registry gives no type) (ClinicalTrials.gov record NCT01869738, source copy `cardio:ctgov-nct01869738-2015-09-02`, retrieved 2026-10-26)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT01869738, source copy `cardio:ctgov-nct01869738-2015-09-02`, retrieved 2026-10-26)
- Completion: 2015-08 (actual) (ClinicalTrials.gov record NCT01869738, source copy `cardio:ctgov-nct01869738-2015-09-02`, retrieved 2026-10-26)
- Countries: United States; Belgium; Czechia; Estonia; Finland; France; Germany; Israel; Netherlands; Poland; Spain; United Kingdom (ClinicalTrials.gov record NCT01869738, source copy `cardio:ctgov-nct01869738-2015-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01869738-2015-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction
- Acronym: MASTER-II
- Condition: ST Elevation Myocardial Infarction
- Intervention (Device): MGuard Prime
- Intervention (Device): (BMS/DES)
- Lead sponsor: InspireMD
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: InspireMD (`cardio:org-inspiremd`)

## Provenance

Content hash: 305d2f26813e9e97d130127662ec93c4b1e589714ea0e75b10098bfad2934fd1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
